The J. M. Smucker SJM
Consumer Defensive · Packaged Foods · Synthos Deep Dive · 2026-07-03
The Overview
Smucker makes food you already know: Folgers and Café Bustelo coffee, Jif peanut butter, Smucker's jams, Uncrustables sandwiches, and Meow Mix / Milk-Bone pet food. Steady, boring, everyday brands.
Is the stock cheap or expensive? Cheap — you pay about $12 for every $1 of "adjusted" yearly profit, roughly half what the average big stock costs, and it pays a 3.8% dividend while you wait. But cheap is cheap for a reason: the company is barely growing — management flat-out says sales will shrink next year — and it borrowed a lot of money ($7 billion) to buy a snack-cake company (Hostess) that then had to be written down twice, producing accounting losses.
Our verdict is Watch — not "buy," not "avoid." It is a fair-value, high-dividend holding for someone who wants income and low drama, but there is no exciting growth story and, importantly, no expert analyst in our research network covers it, so we are relying purely on the numbers.
Here's what the three scores mean in everyday terms:
- Downside Risk 6/10 (a bit above average). The stock itself is calm (it barely moves with the market), but the company carries a lot of debt and keeps taking big write-offs, which raises the risk.
- Growth Quality 3/10 (poor). Sales are flat to falling and profit shrank last year — this is not a growing business.
- Exponential Potential 1/10 (essentially none). Peanut butter and coffee are not going to double this company. Don't expect a moonshot.
The one big worry: coffee is now Smucker's biggest business, and coffee-bean prices swinging (plus tariffs) can whipsaw profits — with $7B of debt and no growth, there's little room for error.
Putting a number on it: our fair-value estimate is $118 against a current price of $132.34 — a premium price for a business we still like.
Our summary metrics
Cheap (11–12× fwd adj EPS) & beta 0.26, but ~4× adj net-debt/EBITDA and serial goodwill write-offs.
FY27 sales guided DOWN 3–4%; adj EPS shrank 10% in FY26; ROIC ~2.5% — a no-growth staple.
Decelerating, mature packaged food; $12B cap in a saturated category — no exponential path.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Decelerating, mature packaged food; $12B cap in a saturated category — no exponential path.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $120.33 (high $137 / low $95 / median $125; 16 Buy · 13 Hold · 2 Sell) — context, not our anchor |
| Valuation | GAAP EPS negative (FY26 net loss); ~12.7× FY26 adj EPS · ~11.6× FY27E · ~10.2× FY30E · EV/S 2.1× · EV/EBITDA ~11–12× (adjusted) |
| Technicals | Mild uptrend — $116, −0.7% off 52-wk high, above 50/200-DMA, RSI 49, but lagging SPY (+13% vs +21% 12-mo) |
| Conviction | Low — 0 expert voices, 0 claims in the Synthos KB; call rests entirely on fundamentals + quant |
| Position sizing | Income/defensive sleeve only, ≤2% — a yield-and-value holding, not a compounder |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for SJM — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $132.34, 13% above the 50-day average ($118), 24% above the 200-day average ($106) — an uptrend. 0% below the 52-week high of $132, 48% above the 52-week low of $90.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $132.34 is currently at/above the upper band (stretched) (band $113–$132).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 72.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently above its signal line by 1.05, positive momentum.
Relative performance vs S&P 500 & its sector (XLP (sector)), set to 100 a year ago
Solid = SJM · dashed = S&P 500 · dotted = XLP (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
The J. M. Smucker Company (NYSE: SJM), founded 1897 and headquartered in Orrville, Ohio, is an American packaged-food and beverage maker. Its fiscal year ends April 30. The portfolio spans coffee (Folgers, Café Bustelo, Dunkin' licensed, 1850), spreads and staples (Jif peanut butter, Smucker's jams/preserves), frozen (Uncrustables sandwiches — the growth engine), and pet food (Meow Mix, Milk-Bone, Pup-Peroni, 9Lives). In 2023 it acquired Hostess Brands (Twinkies, sweet baked snacks) for ~$4.6B — a deal that has since driven two large goodwill/trademark impairments.
Revenue mix (FY2026, from FMP segmentation):
- By product/segment: U.S. Retail Coffee $3.77B (42%) · U.S. Retail Consumer Foods $1.85B (20%) · U.S. Retail Pet Foods $1.60B (18%) · Sweet Baked Snacks (Hostess) $0.97B (11%) · International & Away-From-Home the remainder. Coffee is now the dominant profit and revenue driver — a shift that concentrates commodity risk.
- By geography: United States $8.57B (~96%) · Canada $0.34B. This is an essentially domestic, U.S.-concentrated business — limited FX exposure, but no international growth lever either.
The strategic story is portfolio pruning, not expansion: Smucker divested Voortman (Dec 2024) and certain Sweet Baked Snacks value brands (Mar 2025), and management frames FY27 as "focused organic volume growth" on Uncrustables, coffee, and pet — while the top line still shrinks.
2. The expert thesis — why the panel is bullish (traceable)
There is no expert coverage of SJM in the Synthos knowledge base. total_claims = 0, net_bullish_voices = 0, and the top list is empty. No conviction voice — bullish or bearish — has been distilled for this name.
That is an honest and important fact, not a formatting gap: every number and judgment in this note is fundamentals- and quant-driven, derived from the company's own filings, FMP analyst consensus, and management's self-reported guidance. There are zero claim_id values to cite, and we will not manufacture conviction we do not have. Readers who weight this note should treat it as a quantitative/valuation read, not an expert-panel call. Where the qualitative record exists at all, it is management's own guidance (§9), which we half-weight by design.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 6 · Above average | Valuation is low (11–12× fwd adj EPS) and beta is 0.26, which cap price risk — but adjusted net-debt/EBITDA ~4×, back-to-back Hostess goodwill impairments, and a 28% max drawdown from peak raise the fundamental risk above what a "cheap staple" label implies. |
| Growth Quality | 3 · Poor | Management guides FY27 revenue down 3–4%; adjusted EPS fell 10% in FY26; ROIC ~2.5%, ROE negative on GAAP. Uncrustables and pet are bright spots, but the blended business is a no-grower. |
| Exponential Potential | 1 · None | Mature, decelerating packaged food in a saturated U.S. category; a $12B cap with negative revenue guidance has no exponential path. This is the opposite of a next-exponential. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, and the cases bound the range.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Coffee costs/tariffs ease, Uncrustables + pet drive a return to low-single-digit volume growth, deleveraging continues. FY27 adj EPS lands top-of-guide ~$10.25 and re-rates to a peer ~13.5×. | ~$140 (+20%) |
| Base (our anchor) | Guidance roughly holds — FY27 adj EPS ~$10.00 on sales −3.5%; a no-growth-but-stable staple holds its current ~11.8× adj multiple. | ~$118 (+1.5%) |
| Bear | Coffee pricing rolls over faster than costs, volume declines deepen, a third impairment or a dividend-strain scare; adj EPS slips to ~$9 and the multiple de-rates to ~9.8×. | ~$88 (−24%) |
Synthos fair value = the base case, ~$118 (+1.5%), with the full $88–$140 span as the honest range. Our base sits essentially on top of the Street's $120 consensus — appropriate, because with no growth to argue about and no expert edge, this is a valuation-anchored name where we have no reason to diverge materially from the crowd. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers). SJM is neither — it is a mature, low-return staple:
- Forward growth: revenue is roughly flat-to-down — FY26 $9.05B, and management guides FY27 down 3–4% to ~$8.7B. Consensus revenue barely reaches ~$9.1B by FY30E. EPS "growth" is largely cost/pricing- and share-count-driven, not volume-driven.
- Acceleration (2nd derivative) is negative: FY26 sales +3.7% (helped by coffee price inflation) turns to guided FY27 −3.5%. The apparent FY26 growth was price, not volume (comparable sales: +10pts price, −4pts volume). As coffee prices normalize, the top line rolls over.
- Room to run: none in the exponential sense. U.S. peanut butter, jam, and shelf-coffee are saturated, low-single-digit-TAM categories. At a $12B cap in these markets, there is no realistic path to a multibagger.
- Reinvestment runway: capex guided to just $325M in FY27 (~3.6% of sales) — a harvest-mode, low-reinvestment profile. Cash goes to the dividend and debt paydown, not growth.
Exponential Potential: None (1/10). Own SJM, if at all, for yield and stability, not for growth. This is a bond-proxy staple, and we score it honestly.
5. Financials (real numbers — FMP annual/quarterly + FY26 earnings release)
- Revenue: FY26 $9.05B, +3.7% (FY25 $8.73B; FY24 $8.18B). The FY26 gain was driven by ~+10pts of coffee/sweet-baked pricing against −4pts of volume — i.e., inflation-led, not demand-led.
- GAAP earnings — read the footnotes: FY26 posted a net loss of −$138.7M, EPS −$1.30, and FY25 a −$1.23B loss (−$11.57). Both were driven by large non-cash goodwill/trademark impairments tied to the Hostess/Sweet Baked Snacks unit. On an adjusted basis, FY26 EPS was $9.15 (−10% YoY) — the number the business actually earns in cash terms.
- Quarterly trajectory: the GAAP line is noisy (Q3'26 −$6.79 on the impairment; Q4'26 +$3.64 on a tax/gain swing). Adjusted EPS is the cleaner signal: Q4'26 adj EPS $2.77, +20% YoY — a genuinely strong finish that management is leaning on.
- Margins: gross 33.5% TTM; adjusted operating margin mid-teens. Management guides FY27 adjusted gross margin to ~38% — a meaningful step-up if achieved, the crux of the "earnings growth despite falling sales" story.
- Cash flow (the real strength): FY26 operating cash flow $1.47B, capex −$317M, free cash flow $1.16B (up from $817M in FY25) — a ~9.3% FCF yield on market cap. FCF comfortably covers the $465M dividend and funded $720M of debt repayment in FY26.
- Balance sheet (the real weakness): net debt ~$7.03B. On impairment-depressed TTM EBITDA the reported net-debt/EBITDA is a scary 6.8×, but on normalized/adjusted EBITDA (~$1.7–1.9B) it is ~3.7–4.1× — still elevated for a staple, a direct legacy of the Hostess deal. Current ratio 0.78 (below 1). Deleveraging is underway and is the key balance-sheet watch item.
6. Valuation — priced in or room?
On GAAP, SJM screens as loss-making (impairments), so the honest lens is adjusted earnings and cash flow:
- ~12.7× FY26 adjusted EPS ($9.15) · ~11.6× FY27E ($10.00 mid-guide) · ~10.2× FY30E ($11.44 cons). That is a discount to the packaged-food group and well below the market.
- EV/EBITDA ~11–12× (adjusted), EV/Sales 2.1×, P/FCF ~10.7×, FCF yield ~9.3%, dividend yield ~3.8%.
- Reverse read: at ~11.6× flat FY27 earnings with a 3.8% yield, the market is pricing SJM as a no-growth-but-durable cash cow. That is roughly fair — the cheapness is earned by the negative growth guidance and the leverage, not a mispricing.
- Street targets (context): consensus $120.33, high $137, low $95, median $125; grades 16 Buy / 13 Hold / 2 Sell ("Buy" consensus). FMP's quant letter rating is a middling C+ (overall score 2/5) — low marks on ROE, ROA, and leverage, offsetting a decent DCF score. Our ~$118 base is essentially in line with consensus; we have no expert edge to justify straying.
Not a value trap in the classic sense (the FCF and dividend are real and covered), but not a bargain either — a fairly-priced, high-yield staple.
7. Technicals (computed from EOD price history)
- Trend: mildly up. $116.28 sits above the 50-DMA ($104.64) and 200-DMA ($103.67), with the 50 above the 200 (constructive posture). MACD +2.95 (positive).
- Location: just −0.7% off the 52-week high ($117.05), +30% off the 52-week low ($89.53). Note the max drawdown from peak of −28.5% over the window — this is not a low-volatility-of-price name despite its low beta; staples-multiple compression cuts deep.
- Momentum: RSI(14) 49 — dead neutral, neither overbought nor oversold. No stretched-entry signal either way.
- Relative strength (the tell): SJM +12.9% 12-mo vs SPY +20.6% — it has lagged the market over the year, though it beat SPY over 3 months (+21.8% vs +13.7%) on the strong Q4 print. Persistent 12-month underperformance is consistent with a low-growth staple in a risk-on tape.
- Read: technicals are neutral-to-mildly-positive and do not argue for urgency. A name this cheap with this yield near its highs is fine to accumulate slowly; there is no technical breakout thesis.
8. Moat & competitive position
Smucker's moat is brand equity in low-differentiation categories: Jif, Smucker's, Folgers, and Uncrustables hold strong shelf positions, and Uncrustables in particular is a genuine share-gaining, hard-to-replicate frozen franchise. But the moat is narrow and eroding at the edges: coffee and jam are commodity-input, private-label-exposed categories with limited pricing durability, and the pet-food segment competes against far larger, better-resourced players. The Hostess/sweet-baked bet has underperformed (two impairments), undercutting management's M&A credibility. Net: a stable but low-return moat, not a widening one.
Peer set (FMP-supplied, market cap): Conagra $6.9B, Campbell Soup $7.0B, Hormel $13.8B, Molson Coors $7.5B, Lamb Weston $6.3B, Ingredion $6.2B, Pilgrim's Pride $6.8B, Sprouts Farmers Market $8.5B, Albertsons $6.9B, Coca-Cola Consolidated $15.4B. SJM sits mid-pack on size; like most of this group it trades at a low-double-digit earnings multiple with low-single-digit growth. The whole packaged-food cohort is de-rated — SJM is not an outlier, cheap or expensive.
9. Management, capital allocation & guidance
- Capital allocation: disciplined-defensive. FY26 returned $465M in dividends and repaid $720M of debt — deleveraging is the stated priority, appropriate given ~4× adjusted leverage. Buybacks are negligible. Low capex ($325M guided FY27). The strategic knock is the Hostess acquisition (~$4.6B, 2023), which triggered two goodwill/trademark write-downs — a real capital-allocation misstep that the market has not forgotten.
- Insider activity: the sampled window shows a cluster of officer sales in late June 2026 — CEO Mark Smucker (−13,000 sh @ $115.11, 6/17), CFO Tucker Marshall (−3,630 @ $111.05, 6/24), Chief Legal Officer (−4,353 @ $115.08), Chief People Officer (−5,000 @ $116.70) — alongside routine director stock-unit awards. These are modest, likely-scheduled (post-earnings-window) sales near 52-week highs, not an alarming signal on their own, but the timing (right after the strong Q4 print, near highs) is worth noting rather than ignoring.
- Management's own guidance (the earnings-call track — half-weighted, self-interested): the FY26 Q4 release (SEC 8-K, filed 2026-06-09) is a real earnings release and provides explicit FY2027 guidance: net sales down 3.0–4.0%, adjusted EPS $9.75–$10.25 (framed by management as +7–12% YoY off the adjusted base), free cash flow ~$1.0B, capex $325M, adjusted gross margin ~38%, interest expense ~$345M, adjusted tax rate 24.3%, ~107M shares. Management's own words: "we are entering fiscal year 2027 with meaningful momentum… drive focused organic volume growth… improve profitability and accelerate earnings growth" (Mark Smucker, CEO). Synthos read: we take the FCF and dividend coverage as credible (they are cash facts), but half-weight the "momentum/acceleration" framing — the same guidance concedes sales fall 3–4%, so the EPS growth is margin/pricing/share-count engineering, not demand.
10. Catalysts & what to watch
- Next earnings: 2026-08-26 (Q1'27; Street EPS $2.18, revenue ~$2.12B). The key lines: coffee volume vs. pricing (is the price-led FY26 growth reversing?), Uncrustables and pet volume, and adjusted gross margin progress toward the ~38% FY27 target.
- Coffee costs & tariffs: green-coffee prices and any new/changed tariffs are the single biggest swing to the margin story; management explicitly excluded tariff changes from guidance.
- Deleveraging: continued debt paydown and any move in adjusted net-debt/EBITDA below ~3.5× would de-risk the balance sheet.
- Impairment risk: any further write-down of Hostess/Sweet Baked Snacks goodwill would re-confirm the M&A misstep.
- Dividend: a 3.8% yield covered ~2.5× by FCF — watch for a routine annual raise (Dividend-Aristocrat-adjacent history) as a confidence signal.
Thesis tripwires (what would change the call): a cut or freeze to the dividend; adjusted net-debt/EBITDA rising back above ~4.5×; a third goodwill impairment; or two straight quarters of accelerating volume declines in coffee/pet with no margin offset — any of which would push this from Watch toward Avoid. Conversely, a return to positive volume growth with deleveraging below 3.5× would argue for Buy — Tactical.
11. Key risks
- No growth (structural): management guides revenue down; the category is saturated. The bull case is entirely margin/cost/deleveraging, not demand.
- Commodity/coffee concentration: coffee is now ~42% of sales; bean-price and tariff swings whipsaw margins with limited hedging durability.
- Leverage: ~$7B net debt, ~4× adjusted EBITDA, current ratio 0.78 — a levered staple with little cushion for a demand or rate shock.
- M&A / impairment track record: the Hostess deal produced two write-downs; management's capital-allocation credibility is impaired (literally).
- No expert coverage / low conviction: with zero KB claims, this call has no independent expert corroboration — it is a pure quant/fundamental read, which is itself a reason for humility and a Watch rather than a Buy.
- Private label / demand down-trading: value-seeking consumers can substitute store brands in coffee, jam, and peanut butter.
12. Verdict, position sizing & monitoring
Watch. SJM is a cheap (~11–12× forward adjusted EPS), 3.8%-yielding, low-beta consumer staple with genuinely strong free cash flow ($1.16B FY26) that comfortably covers its dividend and funds debt paydown. Those are real virtues. But the case for owning it is capped by three hard facts: management itself guides FY27 revenue down 3–4%, the balance sheet carries ~4× adjusted leverage from a Hostess deal that produced two goodwill impairments, and there is no expert conviction in the Synthos KB to lean on. Fairly valued, no growth, no edge — that is the definition of Watch, not Buy.
- Sizing (if held): income/defensive sleeve only, ≤2% — a yield-and-stability position, never a growth or conviction allocation. Accumulate slowly on weakness toward the rising 200-DMA (~$104) for a better entry and a >4% yield.
- Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print, with special attention to coffee volume/pricing and deleveraging. Upgrade path to Buy — Tactical requires positive volume growth + deleveraging <3.5×; downgrade to Avoid on a dividend cut or a third impairment.
- Single biggest risk: coffee-cost/pricing whipsaw against a levered, no-growth balance sheet — a demand or commodity shock has little cushion to absorb it.
This verdict is logged as a tracked Synthos call as of 2026-07-03 at $116.28.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — there is no expert coverage of SJM in the Synthos knowledge base, and no
claim_idvalues exist to cite. This note is explicitly fundamentals- and quant-driven; fabricated conviction is structurally impossible (claim-ID reconciliation) and none is asserted. - Data as-of: fundamentals 2026-04-30 (FY26/Q4) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K earnings release filed 2026-06-09. Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
- Management caveat: SJM management's FY27 guidance is management's own book, half-weighted by design; the cash-flow/dividend facts are weighted higher than the "momentum/acceleration" framing.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").